» Articles » PMID: 32589980

Machine Learning in Haematological Malignancies

Overview
Journal Lancet Haematol
Specialties Hematology
Oncology
Date 2020 Jun 27
PMID 32589980
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Machine learning is a branch of computer science and statistics that generates predictive or descriptive models by learning from training data rather than by being rigidly programmed. It has attracted substantial attention for its many applications in medicine, both as a catalyst for research and as a means of improving clinical care across the cycle of diagnosis, prognosis, and treatment of disease. These applications include the management of haematological malignancy, in which machine learning has created inroads in pathology, radiology, genomics, and the analysis of electronic health record data. As computational power becomes cheaper and the tools for implementing machine learning become increasingly democratised, it is likely to become increasingly integrated into the research and practice landscape of haematology. As such, machine learning merits understanding and attention from researchers and clinicians alike. This narrative Review describes important concepts in machine learning for unfamiliar readers, details machine learning's current applications in haematological malignancy, and summarises important concepts for clinicians to be aware of when appraising research that uses machine learning.

Citing Articles

A novel method for screening malignant hematological diseases by constructing an optimal machine learning model based on blood cell parameters.

Sun D, Chen W, He J, He Y, Jiang H, Jiang H BMC Med Inform Decis Mak. 2025; 25(1):72.

PMID: 39934810 PMC: 11816569. DOI: 10.1186/s12911-025-02892-1.


Screening of serum biomarkers in patients with PCOS through lipid omics and ensemble machine learning.

Chen J, Chen W, Zhu Z, Xu S, Huang L, Tan W PLoS One. 2025; 20(1):e0313494.

PMID: 39775242 PMC: 11706364. DOI: 10.1371/journal.pone.0313494.


Machine-learning-based predictive classifier for bone marrow failure syndrome using complete blood count data.

Seo J, Lee C, Koh Y, Sun C, Lee J, An H iScience. 2024; 27(11):111082.

PMID: 39502286 PMC: 11535363. DOI: 10.1016/j.isci.2024.111082.


Predicting the efficiency of chidamide in patients with angioimmunoblastic T-cell lymphoma using machine learning algorithm.

Zhang C, Xu J, Gu M, Tang Y, Tang W, Wang J Front Pharmacol. 2024; 15:1435284.

PMID: 39263576 PMC: 11387163. DOI: 10.3389/fphar.2024.1435284.


Application of machine learning in the management of lymphoma: Current practice and future prospects.

Yuan J, Zhang Y, Wang X Digit Health. 2024; 10:20552076241247963.

PMID: 38628632 PMC: 11020711. DOI: 10.1177/20552076241247963.